PharmacoEconomics & Outcomes News

, Volume 691, Issue 1, pp 9–9 | Cite as

RSV vaccine cost effective in high-risk elderly

Non-clinical study
  • 12 Downloads

Reference

  1. Meijboom MJ, et al. RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population. Vaccine : 19 Oct 2013. Available from: URL:  http://dx.doi.org/10.1016/j.vaccine.2013.10.023 PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2013

Personalised recommendations